Preferred Label : D-2-hydroxyglutaric aciduria 1;
Symbol : D2HGA1;
CISMeF acronym : D2HGA; D2HGA1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : D2HGA;
Description : D-2-hydroxyglutaric aciduria is a neurometabolic disorder first described by Chalmers
et al. (1980). Clinical symptoms include developmental delay, epilepsy, hypotonia,
and dysmorphic features. Both a mild and a severe phenotype was characterized (van
der Knaap et al., 1999). The severe phenotype is homogeneous and is characterized
by early infantile-onset epileptic encephalopathy and, often, cardiomyopathy. The
mild phenotype has a more variable clinical presentation.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the D-2-hydroxyglutarate dehydrogenase gene (D2HGD, 609186.0001);
Laboratory abnormalities : D-2-hydroxyglutaric aciduria; Elevated D-2-hydroxyglutaric acid (urine, plasma, CSF); Elevated L-2-hydroxyglutaric acid (urine); Elevated 2-ketoglutarate (urine);
Prefixed ID : #600721;
Origin ID : 600721;
UMLS CUI : C3152055;
Broader ORDO disease(s)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
Validated automatic mappings to NTBT